NDC 63323-280-01 - Furosemide
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 63323-280
- Requested NDC
- 63323-280-01
- Package NDCs from labels
- 63323-280-01, 63323-280-02, 63323-280-03, 63323-280-04, 63323-280-05, 63323-280-10, 63323-280-41, 63323-280-16, 63323-280-43, 63323-280-26, 63323-280-45, 63323-280-36
- Manufacturer
- Cardinal Health 107, LLC
- Effective date
- 2026-10-26
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Furosemide - Cardinal Health 107, LLC | Cardinal Health 107, LLC | 2026-10-26 | HUMAN PRESCRIPTION DRUG LABEL |
| Furosemide - Cardinal Health 107, LLC | Cardinal Health 107, LLC | 2026-06-02 | HUMAN PRESCRIPTION DRUG LABEL |
| Furosemide - Fresenius Kabi USA, LLC | Fresenius Kabi USA, LLC | 2024-12-09 | HUMAN PRESCRIPTION DRUG LABEL |
| Furosemide - Fresenius Kabi USA, LLC | Fresenius Kabi USA, LLC | 2024-12-09 | HUMAN PRESCRIPTION DRUG LABEL |
| FUROSEMIDE - HF Acquisition Co LLC, DBA HealthFirst | HF Acquisition Co LLC, DBA HealthFirst | 2024-01-28 | HUMAN PRESCRIPTION DRUG LABEL |
| FUROSEMIDE - HF Acquisition Co LLC, DBA HealthFirst | HF Acquisition Co LLC, DBA HealthFirst | 2024-01-22 | HUMAN PRESCRIPTION DRUG LABEL |
| FUROSEMIDE - HF Acquisition Co LLC, DBA HealthFirst | HF Acquisition Co LLC, DBA HealthFirst | 2021-06-28 | HUMAN PRESCRIPTION DRUG LABEL |
| Model AA-8565CV-ACT Model AA-8565CV - Aerospace Accessory Service, Inc | Aerospace Accessory Service, Inc | 2021-05-18 | MEDICAL DEVICE |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 63323-280-01 | Furosemide | 2 mL in 1 VIAL | INJECTION, SOLUTION | 2 | 6 | |
| 63323-280-02 | Furosemide | 25 in 1 TRAY | INJECTION, SOLUTION | 25 | 6 | |
| 63323-280-03 | Furosemide | 4 mL in 1 VIAL | INJECTION, SOLUTION | 4 | 6 | |
| 63323-280-04 | Furosemide | 25 in 1 TRAY | INJECTION, SOLUTION | 25 | 6 | |
| 63323-280-05 | Furosemide | 10 mL in 1 VIAL | INJECTION, SOLUTION | 10 | 6 | |
| 63323-280-10 | Furosemide | 25 in 1 TRAY | INJECTION, SOLUTION | 25 | 6 | |
| 63323-280-16 | Furosemide | 25 in 1 TRAY | INJECTION, SOLUTION | 25 | 5 | |
| 63323-280-26 | Furosemide | 25 in 1 TRAY | INJECTION, SOLUTION | 25 | 5 | |
| 63323-280-36 | Furosemide | 25 in 1 TRAY | INJECTION, SOLUTION | 25 | 5 | |
| 63323-280-41 | Furosemide | 2 mL in 1 VIAL | INJECTION, SOLUTION | 2 | 5 | |
| 63323-280-43 | Furosemide | 4 mL in 1 VIAL | INJECTION, SOLUTION | 4 | 5 | |
| 63323-280-45 | Furosemide | 10 mL in 1 VIAL | INJECTION, SOLUTION | 10 | 5 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 63323-280 | FUROSEMIDE INJECTION, SOLUTION [FRESENIUS KABI USA, LLC] | 6 | Current NDC, Legacy NDC, 6 package rows | 20241222_c794c95a-654e-48fe-9596-201fc122ff75.zip |
| 63323-280 | FUROSEMIDE INJECTION, SOLUTION [FRESENIUS KABI USA, LLC] | 5 | Current NDC, Legacy NDC, 6 package rows | 20241222_3747bbcd-783d-4baa-bb5b-b6827bf390e3.zip |
DailyMed Billing Units#
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| FUROSEMIDE | ACTIVE INGREDIENT | 7LXU5N7ZO5 | FUROSEMIDE INJECTION, SOLUTION [APP PHARMACEUTICALS, LLC] | 1 | |
| FUROSEMIDE | ACTIVE MOIETY | 7LXU5N7ZO5 | FUROSEMIDE INJECTION, SOLUTION [APP PHARMACEUTICALS, LLC] | 1 | |
| HYDROCHLORIC ACID | INACTIVE INGREDIENT | QTT17582CB | FUROSEMIDE INJECTION, SOLUTION [APP PHARMACEUTICALS, LLC] | 1 | |
| SODIUM CHLORIDE | INACTIVE INGREDIENT | 451W47IQ8X | FUROSEMIDE INJECTION, SOLUTION [APP PHARMACEUTICALS, LLC] | 1 | |
| SODIUM HYDROXIDE | INACTIVE INGREDIENT | 55X04QC32I | FUROSEMIDE INJECTION, SOLUTION [APP PHARMACEUTICALS, LLC] | 1 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Atropine Sulfate | ATROPINE SULFATE INJECTION | Medefil, Inc. | fbfdf718-befe-ad22-e053-6294a90a3715 | 2025-12-23 | Warnings, Adverse reactions | 03J5ZE7KA5 |
| ACETAMINOPHEN 500 MG | ACETAMINOPHEN | Pioneer Life Sciences, LLC | 0d67bb52-7ae3-439e-9e47-4e21eb0ca352 | 2025-12-23 | Warnings | 362O9ITL9D |
| Hand Sanitizer Solution 101 | BENZALKONIUM CHLORIDE | Morgan Gallacher Inc. DBA Custom Chemical Formulators Inc. | 81fa10d3-6dbb-4a72-bfff-2dd795f94968 | 2025-12-23 | Warnings | F5UM2KM3W7 |
| MG DermaWash | BENZALKONIUM CHLORIDE | Morgan Gallacher Inc. DBA Custom Chemical Formulators Inc. | 0bb37363-418f-46c7-8c39-9ef9aa5023f7 | 2025-12-23 | Warnings | F5UM2KM3W7 |
| NIGHT TIME SLEEP-AID | DIPHENHYDRAMINE HCL | Discount Drug Mart | ac1860cb-da95-45bf-9261-19f39c56ddfe | 2025-12-23 | Warnings | TC2D6JAD40 |
| Antibacterial Foam | BENZALKONIUM CHLORIDE | SC Johnson Professional USA Inc. | df36ccda-b9cb-41ba-8d4d-56ec447e63df | 2025-12-23 | Warnings | F5UM2KM3W7 |
| Allergy Relief | DIPHENHYDRAMINE HCL 25 MG | Pioneer Life Sciences, LLC | ab45ae97-7951-4058-e053-2995a90a7b2e | 2025-12-23 | Warnings | TC2D6JAD40 |
| Members Mark Arthritis Pain | ACETAMINOPHEN | Sam's West Inc | 4cbe2880-fea9-4d7b-9e7f-a0c794864a84 | 2025-12-23 | Warnings | 362O9ITL9D |
| Allergy Relief | DIPHENHYDRAMINE HCL 25 MG | Pioneer Life Sciences, LLC | ab45ed16-86bb-3faf-e053-2995a90acfbc | 2025-12-23 | Warnings | TC2D6JAD40 |
| MG DermaGel 62 LV | ETHYL ALCOHOL | Morgan Gallacher Inc. DBA Custom Chemical Formulators Inc. | 437a508d-31ba-49b4-b821-4bf57b596e33 | 2025-12-23 | Warnings | 3K9958V90M |
| Allergy Relief | DIPHENHYDRAMINE HCL 25 MG | Pioneer Life Sciences, LLC | a7999da7-148a-4c6d-a2ea-0f4cc1d5b283 | 2025-12-23 | Warnings | TC2D6JAD40 |
| Hydrocodone Bitartrate and Acetaminophen | HYDROCODONE BITARTRATE AND ACETAMINOPHEN | Cranbury Pharmaceuticals, LLC | d8fe4ae4-bd19-42eb-b74d-f302b3f914ee | 2025-12-23 | Boxed warning, Warnings, Adverse reactions | 362O9ITL9D |
| Antibacterial Liquid Hand | BENZALKONIUM CHLORIDE | Morgan Gallacher Inc. DBA Custom Chemical Formulators Inc. | ea0a5970-e95f-4090-bbe3-7df9e04393b5 | 2025-12-23 | Warnings | F5UM2KM3W7 |
| ACETAMINOPHEN 500 MG | ACETAMINOPHEN | Pioneer Life Sciences, LLC | 11e6ec2a-5171-4496-a15f-6ff744bd1f2f | 2025-12-23 | Warnings | 362O9ITL9D |
| Oxycodone and Acetaminophen | OXYCODONE AND ACETAMINOPHEN | Aurolife Pharma, LLC | 69df20d9-b1d5-47dc-9ff0-29987284f8c7 | 2025-12-23 | Boxed warning, Warnings, Adverse reactions | 362O9ITL9D |
| Hydrocodone Bitartrate and Acetaminophen | HYDROCODONE BITARTRATE AND ACETAMINOPHEN | Cranbury Pharmaceuticals, LLC | d4caec6d-4af2-4f1c-9add-c0c948b83b16 | 2025-12-23 | Boxed warning, Warnings, Adverse reactions | 362O9ITL9D |
| Acetaminophen and Codeine Phosphate | ACETAMINOPHEN AND CODEINE PHOSPHATE | Aurolife Pharma, LLC | 02386806-02d4-47e3-9c8b-7810146ee795 | 2025-12-23 | Boxed warning, Warnings, Adverse reactions | 362O9ITL9D |
| MG DermaClean | N/A | Morgan Gallacher Inc. | ed3d983e-0a6e-4de4-832a-0020f7711011 | 2025-12-23 | Warnings | F5UM2KM3W7 |
| Safetussin High Blood Pressure and diabetes Cough, Cold and Flu | ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, AND GUAIFENESIN | KRAMER LABORATORIES | 279e309c-040d-4001-808d-b7d986a9a1d8 | 2025-12-23 | Warnings | 362O9ITL9D |
| MG DermaSan | N/A | Morgan Gallacher Inc. | d4c0de39-8570-4a05-a5e3-3752545ed95f | 2025-12-23 | Warnings | F5UM2KM3W7 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.